Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9211 |
High Similarity |
NPD6801 |
Discontinued |
0.9097 |
High Similarity |
NPD7075 |
Discontinued |
0.906 |
High Similarity |
NPD6799 |
Approved |
0.9007 |
High Similarity |
NPD5403 |
Approved |
0.8968 |
High Similarity |
NPD3817 |
Phase 2 |
0.8903 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD5401 |
Approved |
0.8854 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD5402 |
Approved |
0.8831 |
High Similarity |
NPD4380 |
Phase 2 |
0.8727 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.872 |
High Similarity |
NPD6797 |
Phase 2 |
0.8712 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD6599 |
Discontinued |
0.8667 |
High Similarity |
NPD7251 |
Discontinued |
0.8662 |
High Similarity |
NPD2801 |
Approved |
0.8658 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8642 |
High Similarity |
NPD6166 |
Phase 2 |
0.8642 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8642 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD7808 |
Phase 3 |
0.86 |
High Similarity |
NPD1549 |
Phase 2 |
0.8599 |
High Similarity |
NPD1934 |
Approved |
0.8571 |
High Similarity |
NPD1512 |
Approved |
0.8553 |
High Similarity |
NPD3882 |
Suspended |
0.8545 |
High Similarity |
NPD7472 |
Approved |
0.8544 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD3818 |
Discontinued |
0.8535 |
High Similarity |
NPD7411 |
Suspended |
0.8485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8467 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8442 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8438 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8387 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8313 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8261 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8243 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8129 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8129 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8129 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD920 |
Approved |
0.8049 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8034 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7925 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7904 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD919 |
Approved |
0.7881 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7834 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7799 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7763 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7736 |
Intermediate Similarity |
NPD6190 |
Approved |
0.773 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7703 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7613 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7613 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7613 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7613 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7588 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7436 |
Intermediate Similarity |
NPD943 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7434 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7403 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD37 |
Approved |
0.7378 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7301 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7292 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2798 |
Approved |
0.725 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5710 |
Approved |
0.724 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7229 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD411 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7176 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7159 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1608 |
Approved |
0.712 |
Intermediate Similarity |
NPD4287 |
Approved |
0.712 |
Intermediate Similarity |
NPD7697 |
Approved |
0.712 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.712 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7112
|
Intermediate Similarity |
NPD4361 |
Phase 2 |